Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Dry Eye Syndrome Drugs Market 2017-2021 - Key Vendors are Allergan, Novartis, Otsuka Holdings & Santen Pharmaceutical - Research and Markets

Research and Markets
Posted on: 01 Nov 17

The "Global Dry Eye Syndrome Drugs Market 2017-2021" report has been added to Research and Markets' offering.

The global dry eye syndrome drugs market to grow at a CAGR of 7.59% during the period 2017-2021.

Global Dry Eye Syndrome Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is Initiatives and programs for supporting patients with ophthalmic disorders. Public awareness about problems related to visual impairment has increased in the last decade because of the increase in the number of government initiatives undertaken by various organizations.

According to the report, one driver in the market is untapped potential in developing countries. Countries such as India, China, and Brazil are some of the most attractive countries for pharmaceutical companies globally. Several factors are responsible for the high growth of the healthcare sector in developing countries. Vast population, growing geriatric population, and lifestyle disorders such as obesity and diabetes that lead to dry eye syndrome are factors expected to drive the market in developing countries.

Further, the report states that one challenge in the market is lack of ophthalmology experts. The lack of trained ophthalmologists who have expertise in treating eye disorders such as dry eyes is one of the key challenges in the market. Although the number of people diagnosed with or prone to eyesight disorders has been on the rise, there are insufficient trained and experienced eye care professionals (ophthalmologists, optometrists, ophthalmic assistants, and ophthalmic nurses) to treat eye disorders. For instance, in Europe, there is just one ophthalmologist for every 8,000 individuals.

Key vendors

  • Allergan
  • Novartis
  • Otsuka Holdings
  • Santen Pharmaceutical

Other prominent vendors

  • Aerie Pharmaceutical
  • Akorn
  • Bausch & Lomb
  • Johnson & Johnson
  • Merck
  • MIMETOGEN
  • ReGenTree
  • Sun Pharmaceutical
  • Teva Pharmaceutical

Key Topics Covered:

  1. Executive Summary
  2. Scope Of The Report
  3. Research Methodology
  4. Introduction
  5. Market Landscape
  6. Pipeline Landscape
  7. Market Segmentation By Product
  8. Regional Landscape
  9. Decision Framework
  10. Drivers And Challenges
  11. Market Trends
  12. Vendor Landscape
  13. Key Vendor Analysis
  14. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/h5rv7d/global_dry_eye

View source version on businesswire.com: http://www.businesswire.com/news/home/20171101006181/en/

Business Wire
www.businesswire.com

Last updated on: 01/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.